Skip to main navigation

Skip links

  • Skip to content
  • Skip to footer

Akari TX

Main navigation

Menu
  • Home
  • About
    • Company Overview
    • Management
    • Board of Directors
  • Areas of Focus
    • Pipeline
    • Science
    • HSCT-TMA
    • Nomacopan in HSCT-TMA
    • Geographic Atrophy (GA)
    • PAS-Nomacopan in GA
  • Investor Relations
    • Overview
    • General Meeting of Shareholders
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
    • News & Presentations
      • Press Releases
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Email Alerts
  • Press
    • Press Releases
    • Stories
  • Contact Us

POS AM

SEC Filing Details

Document Details

Form
POS AM
Filing Date
Sep 30, 2021
Document Date
Sep 30, 2021
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact Us

Footer

Follow Us

Terms of Use
Privacy Statement
Expanded Access
Contact Us

Akari TX

Copyright © 2023 Akari Therapeutics Plc. All rights reserved.